Search research articles
Contact Us
Filters
Showing results (11-20 of 66) with videos related to
Page
of 7
Sort By:
Internal Medicine Journal
|
August 23, 2021
Use of telehealth to increase treatment access for prisoners with chronic hepatitis C
Abir Halder, Vicky Guizhi Li, Marilyn Sebastian, et al.
Journal of Opioid Management
|
May 20, 2015
Positive subjective measures in abuse liability studies and real-world nonmedical use: Potential impact of abuse-deterrent opioids on rates of nonmedical use and associated healthcare costs
Alan G White, Joseph LeCates, Howard G Birnbaum, et al.
International Journal of Nursing Practice
|
August 2, 2016
Nurse-led hepatocellular carcinoma surveillance clinic provides an effective method of monitoring patients with cirrhosis
Saroj Nazareth, Nadine Leembruggen, Rhoda Tuma, et al.
Drug and Alcohol Dependence
|
February 12, 2011
Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trial
Frances R Levin, John J Mariani, Daniel J Brooks, et al.
Cellular Immunology
|
June 29, 2010
Toll-like receptor (TLR) expression on CD4+ and CD8+ T-cells in patients chronically infected with hepatitis C virus
Talia Hammond, Silvia Lee, Mark W Watson, et al.
Immunology and Cell Biology
|
July 13, 2006
Hepatitis C virus genotype and HIV coinfection affect cytokine mRNA levels in unstimulated PBMC but do not shift the T1/T2 balance
Silvia Lee, Mark W Watson, Ben Clark, et al.
Biochemistry
|
November 19, 2003
Biophysical characterization of the interactions of HTI-286 with tubulin heterodimer and microtubules
Girija Krishnamurthy, Wendy Cheng, Mei-Chu Lo, et al.
Internal Medicine Journal
|
March 10, 2025
Reduced survival for rural patients with hepatocellular carcinoma within a tertiary hospital network: treatment equality is not enough
Andrew Chin, Ali Galalah Mostafa Ismail, Weiyuan Fan, et al.
The Journal of Infectious Diseases
|
November 19, 2003
Interferon-gamma response by peripheral blood mononuclear cells to hepatitis C virus core antigen is reduced in patients with liver fibrosis
Mark W Watson, Aleksandra Jaksic, Patricia Price, et al.
Disease Markers
|
July 2, 2010
Decreased IP-10 and elevated TGFbeta1 levels are associated with viral clearance following therapy in patients with hepatitis C virus
Silvia Lee, Julius Varano, James P Flexman, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 66) with videos related to
Sort By:
Page
of 7
Internal Medicine Journal
|
August 23, 2021
Use of telehealth to increase treatment access for prisoners with chronic hepatitis C
Abir Halder, Vicky Guizhi Li, Marilyn Sebastian, et al.
Journal of Opioid Management
|
May 20, 2015
Positive subjective measures in abuse liability studies and real-world nonmedical use: Potential impact of abuse-deterrent opioids on rates of nonmedical use and associated healthcare costs
Alan G White, Joseph LeCates, Howard G Birnbaum, et al.
International Journal of Nursing Practice
|
August 2, 2016
Nurse-led hepatocellular carcinoma surveillance clinic provides an effective method of monitoring patients with cirrhosis
Saroj Nazareth, Nadine Leembruggen, Rhoda Tuma, et al.
Drug and Alcohol Dependence
|
February 12, 2011
Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trial
Frances R Levin, John J Mariani, Daniel J Brooks, et al.
Cellular Immunology
|
June 29, 2010
Toll-like receptor (TLR) expression on CD4+ and CD8+ T-cells in patients chronically infected with hepatitis C virus
Talia Hammond, Silvia Lee, Mark W Watson, et al.
Immunology and Cell Biology
|
July 13, 2006
Hepatitis C virus genotype and HIV coinfection affect cytokine mRNA levels in unstimulated PBMC but do not shift the T1/T2 balance
Silvia Lee, Mark W Watson, Ben Clark, et al.
Biochemistry
|
November 19, 2003
Biophysical characterization of the interactions of HTI-286 with tubulin heterodimer and microtubules
Girija Krishnamurthy, Wendy Cheng, Mei-Chu Lo, et al.
Internal Medicine Journal
|
March 10, 2025
Reduced survival for rural patients with hepatocellular carcinoma within a tertiary hospital network: treatment equality is not enough
Andrew Chin, Ali Galalah Mostafa Ismail, Weiyuan Fan, et al.
The Journal of Infectious Diseases
|
November 19, 2003
Interferon-gamma response by peripheral blood mononuclear cells to hepatitis C virus core antigen is reduced in patients with liver fibrosis
Mark W Watson, Aleksandra Jaksic, Patricia Price, et al.
Disease Markers
|
July 2, 2010
Decreased IP-10 and elevated TGFbeta1 levels are associated with viral clearance following therapy in patients with hepatitis C virus
Silvia Lee, Julius Varano, James P Flexman, et al.
Page
of 7